On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q3 2023 earnings per share (EPS) of -$0.40, up 71.43% year over year. Total Aileron Therapeutics earnings for the quarter were -$1.83 million. In the same quarter last year, Aileron Therapeutics's earnings per share (EPS) was -$1.40.
As of Q1 2024, Aileron Therapeutics's earnings has grown year over year. Aileron Therapeutics's earnings in the past year totalled -$12.94 million.
What is ALRN's earnings date?
Aileron Therapeutics's earnings date is Invalid Date. Add ALRN to your watchlist to be reminded of ALRN's next earnings announcement.
What was ALRN's revenue last quarter?
On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aileron Therapeutics's revenue was $0.00.
What was ALRN's revenue growth in the past year?
As of Q1 2024, Aileron Therapeutics's revenue has grown null year over year. Aileron Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.